Anti-Mumps nucleoprotein antibody [7B10] (ab9880)
Key features and details
- Mouse monoclonal [7B10] to Mumps nucleoprotein
- Suitable for: WB, Indirect ELISA
- Isotype: IgG2a
Overview
-
Product name
Anti-Mumps nucleoprotein antibody [7B10]
See all Mumps nucleoprotein primary antibodies -
Description
Mouse monoclonal [7B10] to Mumps nucleoprotein -
Host species
Mouse -
Tested applications
Suitable for: WB, Indirect ELISAmore details -
Species reactivity
Reacts with: Mumps virus -
Immunogen
Tissue, cells or virus corresponding to Mumps nucleoprotein. Recombinant mumps NP. Gloucester strain (Glouc 1/UK96)
-
General notes
This product was changed from ascites to tissue culture supernatant on 28/11/2017. Lot numbers higher than GR293636-4 and GR137414-5 will be from tissue culture supernatant. Please note that the dilutions may need to be adjusted accordingly.
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Store at -20°C or -80°C. Avoid freeze / thaw cycle. -
Storage buffer
pH: 7.2
Preservative: 0.1% Sodium azide -
Concentration information loading...
-
Purity
Protein A purified -
Clonality
Monoclonal -
Clone number
7B10 -
Myeloma
NS0/1 -
Isotype
IgG2a -
Light chain type
unknown -
Research areas
Associated products
-
Compatible Secondaries
-
Isotype control
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab9880 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
WB |
1/1000 - 1/5000. Predicted molecular weight: 66 kDa.
|
|
Indirect ELISA |
1/1000 - 1/10000.
|
Notes |
---|
WB
1/1000 - 1/5000. Predicted molecular weight: 66 kDa. |
Indirect ELISA
1/1000 - 1/10000. |
Target
-
Alternative names
- NP antibody
- Nucleocapsid protein antibody
- Nucleoprotein antibody
Images
-
Immunoblot of yeast-derived mumps NP using monoclonal antibody 7B10.
Lane 1 - prestained standard proteins
Lane 2 - mumps NP
Antibody 7B10 at a concentration of 0.5 µg/ml.Immunoblot of yeast-derived mumps NP using monoclonal antibody 7B10.
Lane 1 - prestained standard proteins
Lane 2 - mumps NP
Antibody 7B10 at a concentration of 0.5 µg/ml.
Datasheets and documents
-
SDS download
-
Datasheet download
References (12)
ab9880 has been referenced in 12 publications.
- Duncan CJA et al. Life-threatening viral disease in a novel form of autosomal recessive IFNAR2 deficiency in the Arctic. J Exp Med 219:N/A (2022). PubMed: 35442417
- Chen R et al. Characterization of an Antiviral Component in Human Seminal Plasma. Front Immunol 12:580454 (2021). PubMed: 33679733
- Hao X et al. Development of Improved Mumps Vaccine Candidates by Mutating Viral mRNA Cap Methyltransferase Sites in the Large Polymerase Protein. Virol Sin 36:521-536 (2021). PubMed: 33284397
- Marques RF et al. Protective Malaria Vaccine in Mice Based on the Plasmodium vivax Circumsporozoite Protein Fused with the Mumps Nucleocapsid Protein. Vaccines (Basel) 8:N/A (2020). PubMed: 32325874
- Wu H et al. Mumps virus infection disrupts blood-testis barrier through the induction of TNF-a in Sertoli cells. FASEB J 33:12528-12540 (2019). PubMed: 31450968